10
Apr

Canadian biotech Tekmira Pharmaceuticals is planning to resume its Phase I study of an investigational treatment for Ebola now that the FDA has waved off some lingering safety concerns.

…read more

Source: Tekmira gets the FDA’s OK to resume its Ebola study

    

0 No comments